MARKET

CPRX

CPRX

Catalyst Pharmaceuticals Inc
NASDAQ
24.35
-0.10
-0.41%
After Hours: 24.26 -0.09 -0.37% 19:53 12/26 EST
OPEN
24.38
PREV CLOSE
24.45
HIGH
24.44
LOW
24.08
VOLUME
718.13K
TURNOVER
--
52 WEEK HIGH
26.58
52 WEEK LOW
19.05
MARKET CAP
2.99B
P/E (TTM)
14.21
1D
5D
1M
3M
1Y
5Y
1D
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
NASDAQ · 5d ago
First Week of February 2026 Options Trading For Catalyst Pharmaceuticals (CPRX)
NASDAQ · 6d ago
Weekly Report: what happened at CPRX last week (1215-1219)?
Weekly Report · 6d ago
Wall Street Analysts See a 42.62% Upside in Catalyst (CPRX): Can the Stock Really Move This High?
NASDAQ · 12/17 14:55
Catalyst Pharma Director Makes a Bold Move with Stock Sale!
TipRanks · 12/17 02:02
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now
NASDAQ · 12/16 13:30
Catalyst Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Reuters · 12/15 13:03
Weekly Report: what happened at CPRX last week (1208-1212)?
Weekly Report · 12/15 10:34
More
About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.

Webull offers Catalyst Pharmaceuticals Inc stock information, including NASDAQ: CPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPRX stock methods without spending real money on the virtual paper trading platform.